Overview of Ancillary Techniques in Cervical Cytology.
Cervical screening
Dual staining
Genotyping
High-risk HPV
Methylation
Journal
Acta cytologica
ISSN: 1938-2650
Titre abrégé: Acta Cytol
Pays: Switzerland
ID NLM: 0370307
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
11
2022
accepted:
23
12
2022
medline:
31
3
2023
pubmed:
5
1
2023
entrez:
4
1
2023
Statut:
ppublish
Résumé
The association between high-risk serotypes of human papillomavirus (hr-HPV) and cervical cancer is well-established. In order to improve the sensitivity of cervical cytology testing, hr-HPV testing has rapidly become part of routine cervical cancer screening, either in conjunction with cytology or as primary testing. In this review, we discuss the overall utility and strategies of hr-HPV testing, as well as the advantages and limitations of potential triage strategies for hr-HPV-positive women, including HPV genotyping, p16/Ki-67 dual staining, and methylation assays. hr-HPV testing is discussed as primary screening and HPV genotyping, p16/Ki-67 dual staining, and methylation assays are discussed as ancillary techniques to cytology in the triage of hr-HPV-positive women undergoing cervical cancer screening.
Sections du résumé
BACKGROUND
BACKGROUND
The association between high-risk serotypes of human papillomavirus (hr-HPV) and cervical cancer is well-established.
SUMMARY
CONCLUSIONS
In order to improve the sensitivity of cervical cytology testing, hr-HPV testing has rapidly become part of routine cervical cancer screening, either in conjunction with cytology or as primary testing. In this review, we discuss the overall utility and strategies of hr-HPV testing, as well as the advantages and limitations of potential triage strategies for hr-HPV-positive women, including HPV genotyping, p16/Ki-67 dual staining, and methylation assays.
KEY MESSAGE
CONCLUSIONS
hr-HPV testing is discussed as primary screening and HPV genotyping, p16/Ki-67 dual staining, and methylation assays are discussed as ancillary techniques to cytology in the triage of hr-HPV-positive women undergoing cervical cancer screening.
Identifiants
pubmed: 36599328
pii: 000528931
doi: 10.1159/000528931
doi:
Substances chimiques
Ki-67 Antigen
0
Cyclin-Dependent Kinase Inhibitor p16
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-128Informations de copyright
© 2023 S. Karger AG, Basel.